Release 4 5 Preview #2
This page is part of the FHIR Specification (v4.0.1: R4 - Mixed Normative and STU ). This is the current published version in it's permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions


Clinical Decision Support Work Group Maturity Level : N/A Standards Status : Informative Compartments : Not linked to any defined compartments

This is the narrative for the resource. See also the XML , JSON or Turtle format. This example conforms to the profile PlanDefinition .

Generated Narrative with Details

id : opioidcds-08

url :

identifier : cdc-opioid-guidance (OFFICIAL)

version : 0.1.0

name : cdc-opioid-08

title : CDC Opioid Prescribing Guideline Recommendation #8

type : ECA Rule (Details : { code 'eca-rule' = 'ECA Rule', given as 'ECA Rule'})

status : draft

date : 19/03/2018 2018-03-19

publisher : Centers for Disease Control and Prevention (CDC)

description : Clinicians should incorporate into the management plan strategies to mitigate risk, including considering offering naloxone when factors that increase risk for opioid overdose, such as history of overdose, history of substance use disorder, higher opioid dosages (≥50 MME/day), or concurrent benzodiazepine use, are present.

useContext : ,

jurisdiction : United States of America (Details : {urn:iso:std:iso:3166 code 'US' = 'United States of America', given as 'United States of America'})

purpose : CDC’s Guideline for Prescribing Opioids for Chronic Pain is intended to improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose. The Guideline is not intended for patients who are in active cancer treatment, palliative care, or end-of-life care.

usage : Before starting and periodically during continuation of opioid therapy, clinicians should evaluate risk factors for opioid-related harms.

copyright : © CDC 2016+.

topic : Opioid Prescribing (Details )

author : Kensaku Kawamoto, MD, PhD, MHS: , Bryn Rhodes: , Floyd Eisenberg, MD, MPH: , Robert McClure, MD, MPH:

relatedArtifact : ,

library : Library/opioidcds-recommendation-08


title : Existing patient exhibits risk factors for opioid-related harms.

description : Checking if the trigger prescription meets the inclusion criteria for recommendation #8 workflow.

documentation :

trigger :


- Kind Expression
* applicability

groupingBehavior : visual-group

selectionBehavior : exactly-one


path : action.description

expression :


path : action.title

expression :


path : action.extension

expression :


- Description
* Will offer Naloxone instead
* Risk of overdose carefully considered and outweighed by benefit; snooze 3 mo
* N/A - see comment; snooze 3 mo



Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.